IL151926A0 - Drug for stimulating leucopoiesis and for treating tumour diseases, protozoal diseases, acariasis and arthropodiasis, and process for producing it - Google Patents

Drug for stimulating leucopoiesis and for treating tumour diseases, protozoal diseases, acariasis and arthropodiasis, and process for producing it

Info

Publication number
IL151926A0
IL151926A0 IL15192601A IL15192601A IL151926A0 IL 151926 A0 IL151926 A0 IL 151926A0 IL 15192601 A IL15192601 A IL 15192601A IL 15192601 A IL15192601 A IL 15192601A IL 151926 A0 IL151926 A0 IL 151926A0
Authority
IL
Israel
Prior art keywords
diseases
leucopoiesis
arthropodiasis
acariasis
stimulating
Prior art date
Application number
IL15192601A
Other languages
English (en)
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of IL151926A0 publication Critical patent/IL151926A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL15192601A 2000-03-30 2001-03-29 Drug for stimulating leucopoiesis and for treating tumour diseases, protozoal diseases, acariasis and arthropodiasis, and process for producing it IL151926A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10015814A DE10015814A1 (de) 2000-03-30 2000-03-30 Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung
PCT/EP2001/003609 WO2001072289A2 (de) 2000-03-30 2001-03-29 Arzneimittel zur stimulierung der leukopoese, zur behandlung von tumor- und protozoenerkrankungen, von akarinosis, arthropodiasis und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
IL151926A0 true IL151926A0 (en) 2003-04-10

Family

ID=7636966

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15192601A IL151926A0 (en) 2000-03-30 2001-03-29 Drug for stimulating leucopoiesis and for treating tumour diseases, protozoal diseases, acariasis and arthropodiasis, and process for producing it

Country Status (11)

Country Link
US (1) US20030199476A1 (xx)
EP (1) EP1267943A2 (xx)
JP (1) JP2003528134A (xx)
CN (1) CN1426311A (xx)
AU (1) AU2001263828A1 (xx)
BR (1) BR0109799A (xx)
CA (1) CA2404322A1 (xx)
DE (1) DE10015814A1 (xx)
IL (1) IL151926A0 (xx)
MX (1) MXPA02009434A (xx)
WO (1) WO2001072289A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148067A1 (de) * 2001-09-28 2003-04-17 Max Planck Gesellschaft Hitzesterilisierbare Alkylphosphocholin-Liposome
DE10148066A1 (de) * 2001-09-28 2003-04-24 Max Planck Gesellschaft Liposome enthaltend (Ether)-Lysolecithine
ES2184650B1 (es) * 2001-10-10 2004-09-16 Farmaleis, S.L. Utilizacion de colesterol y fosfolipidos en medicamentos para el tratamiento de la leishmaniasis en los canidos.
ATE491437T1 (de) * 2004-10-19 2011-01-15 Mpg Max Planck Ges Zur Foerderung Der Wissenschaften E V Formulierungen mit alkylphosphocholinen unter verwendung von neuen negativen ladungsträgern
EP1745788A1 (de) 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
BR112015002945B1 (pt) * 2012-08-13 2021-08-31 Adipharm Ead Formulações farmacêuticas contendo derivados de 3-(4-cinamil-1-piperazinil)-amino de 3- formil-rifamicina sv e 3-formil-rifamicina s e um processo para sua preparação
EP3895709A1 (de) 2020-04-17 2021-10-20 Andreas Hettich GmbH & Co. KG Phospholipide und phospholipid-metaboliten zur behandlung von viralen und bakteriellen lungenentzündungen und sepsis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI874742A (fi) * 1987-10-28 1989-04-29 K & V Licencing Oy Foerfarande foer framstaellning av liposomer.
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
EP0880530B1 (de) * 1996-02-16 2003-07-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Phosphatidyloligoglycerine
DE19835611A1 (de) * 1998-08-06 2000-02-10 Max Planck Gesellschaft Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten

Also Published As

Publication number Publication date
DE10015814A1 (de) 2001-10-11
AU2001263828A1 (en) 2001-10-08
EP1267943A2 (de) 2003-01-02
WO2001072289A3 (de) 2002-04-18
JP2003528134A (ja) 2003-09-24
CA2404322A1 (en) 2002-09-24
CN1426311A (zh) 2003-06-25
BR0109799A (pt) 2003-01-21
WO2001072289A2 (de) 2001-10-04
MXPA02009434A (es) 2003-09-22
US20030199476A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
AU2001294604A1 (en) Improved radiation therapy treatment method
PL369398A1 (en) Apparatus and method for bioelectric stimulation, healing acceleration and pain relief
EP1311262A4 (en) COMBINED TREATMENT AGAINST CANCER
IL163102A (en) Dihydrobenzodiazepin-2-one derivatives, process for their preparation and use thereof in the preparation of medicaments for the treatment of neurological disorders
AU2001276039A1 (en) Methods and apparatus for brachytherapy treatment of prostate disease
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
HK1079993A1 (en) Drugs for treating vascular diseases
HUP0402656A3 (en) A cell therapy method for the treatment of tumors
MXPA03003632A (es) Metodo para tratamiento de tumores usando terapia de combinacion.
IL164956A (en) Tablet containing ibandronate for treating bone diseases and process for its preparation
EP1676132A4 (en) SYSTEM AND METHOD FOR THE TREATMENT OF CANCER, IN PARTICULAR CANCERS OF THE CENTRAL NERVOUS SYSTEM
AU2000258352A1 (en) Acupuncture points stimulation for treating various diseases
IL151926A0 (en) Drug for stimulating leucopoiesis and for treating tumour diseases, protozoal diseases, acariasis and arthropodiasis, and process for producing it
MXPA03007036A (es) Metodo de terapia para cancer.
IL148166A0 (en) Drug for treating fractures
HK1098131A1 (en) Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
GB0012186D0 (en) Treatment of cancer and neurological diseases
MXPA03006742A (es) Uso de buprenorfina para la terapia de la incontinencia urinaria.
EP1572089A4 (en) PROCESS FOR THE GROWTH OF HUMAN ORGANS, FOR THE TREATMENT OF DISEASES AND FOR EXTENDING LIFE
IL148189A0 (en) Chemically-stabilized chlorite solutions for treating cancer and other diseases
HUP0203774A3 (en) Use of 2-amino-3,4-dihydro-quinazolines for producing medicaments for treating or preventing diseases caused by ischaemic conditions
ZA200407358B (en) Microorganism for genetic therapeutic treatment ofproliferative diseases.
GB2397018B (en) Combination therapy for treating disease
AU2003213700A8 (en) Immunogens for treatment of neoplastic and infectious disease